A South African community is to challenge German homeopathic giant Schwabe Pharmaceuticals in court in Munich next week over a traditional medicine the company is seeking to patent.

The case could set a precedent in cases in which multinationals use the plants and indigenous knowledge of developing countries, where laws may not protect communities’ intellectual property rights.

Schwabe wants to patent a method for producing extracts from the roots of Pelargonium sidoides and Pelargonium reniforme to make cough and cold syrups. The company has also hit problems in India over alleged bioprospecting.

Read the full article at M&G …

Encouraging the use of traditional African herbal medicines could prevent some of the one million malarial deaths on the continent, according to specialists attending a conference in Nairobi. Many poor communities, especially in rural settings, cannot afford modern malarial drugs and many people die due to inaccessibility of treatment.

“Malaria kills many people in Africa, both children and adults, despite the availability of free treatment in certain African countries. While it is true many governments in Africa, with development partners, give free pediatric treatment for malaria, many still cannot access this facilities and resort to home treatment,” says Merlin Wilcox of the Research Initiative on Traditional Antimalarial Methods and the University of Oxford.
Continue Reading